A Long-term Study of Ba253BINEB in Patients With Bronchial Asthma

Exclusion Criteria

• •1. Patients who have taken an long acting corticosteroids(i.m.) within 1 month before the screening test
• •2. Patients using corticosteroid medication( p.o./ i.h.) at a dose in excess of the equivalent 10 mg/day of prednisolone
• •3. Patients with glaucoma
• •4. Patients who have prostatic hypertrophy
• •5. Patients with hypersensitivity to anticholinergic drugs
• •6. Patients who began treatment with hyposensitization or immunoregulator therapy within 3 month before the screening test
• •7. Patients complicated with chronic bronchitis, emphysema or bronchiectasis, making the assessment of drug efficacy against bronchial asthma difficult
• •8. Patients with serious hepatic disease, kidney disease or heart disorder and who are judged by the investigator as inappropriate as the subjects of study
• •9. Women who are pregnant or who may become pregnant, or nursing women
• •10. Patients who are judged by the investigator as inappropriate as the subjects of the study